Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy

Mater Horiz. 2021 May 1;8(5):1454-1460. doi: 10.1039/d0mh01582b. Epub 2021 Mar 4.

Abstract

A living therapeutic system based on attenuated Salmonella was developed via metabolic engineering using an aggregation-induced emission (AIE) photosensitizer MA. The engineered bacteria could localize in the tumor tissues and continue to colonize and express exogenous genes. Under light irradiation, the encoded VEGFR2 gene was released and expressed in tumor tissues, which can suppress angiogenesis induced by a T cell-mediated autoimmune response and inhibit tumor growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria
  • Humans
  • Immunotherapy
  • Neoplasms* / drug therapy
  • Neovascularization, Pathologic / drug therapy
  • Photosensitizing Agents / therapeutic use

Substances

  • Photosensitizing Agents